European Regulation Spurring Data Value Discoveries

MiFID II, Basel III, EMIR and more are pushing firms to seek overlap in meeting compliance demands, finding common ground in data

chris-johnson-hsbc
Chris Johnson, head of product management, market data services, HSBC Securities Services

The latest securities industry regulations in Europe—MiFID II, MiFIR, BCBS 239, Basel III, Solvency II and EMIR—are having a bigger impact than any assortment of new rules previously seen in any region, and are far-reaching and wide-ranging, said regulatory operations experts who spoke in a recent webcast hosted by Inside Reference Data.

The advent of these new rules has pushed firms to look for areas of overlap in their data operations and the stores of data they regularly collect, the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here